Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Quick Takeaways: Why It Matters? Combining a subscription meal platform with Woof’s refillable enrichment systems (like the Pupsicle) should raise average customer lifetime value, improve retention, and create more cross-sell opportunities in a competitive DTC pet market. Keeping Woof as a...
Quick Takeaways: Why It Matters? Chewy is using the Modern Animal acquisition to bolt a fast-growing, tech-enabled clinic network onto its retail, pharmacy, and insurance stack, expanding Chewy Vet Care from 18 to 47 locations and adding over 125 million dollars in hi...
Quick Takeaways: Why It Matters? Parnell is bolstering its US footprint by buying Noble Pharma, adding an FDA and DEA‑accredited plant in Wisconsin with broad dosage-form capabilities to secure supply and support portfolio growth. The acquisition turns Noble’s CDMO-style ...
Quick Takeaways: Why It Matters? The VievePharm deal gives Zenex a certified Western European manufacturing and sales base plus advanced bolus technology, accelerating its shift from an India‑focused player to a global naturals-led animal health company alig...
Quick Takeaways: Why It Matters? By unifying PIMS, AI scribing, and decision support (Plumb’s, Standards of Care, etc.) in one intelligence-native stack, Instinct is positioning itself as a full operating platform for modern hospitals, which could pressure legacy PIMS vendors t...
